carbon monoxide has been researched along with Heroin Abuse in 3 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Smoking cessation rates in methadone-maintained smokers are low and novel treatment strategies are required." | 9.17 | Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial. ( Anderson, BJ; Audet, D; Caviness, CM; Kurth, ME; Olson, J; Stein, MD, 2013) |
| " Smoking cessation rates in methadone-maintained smokers are low and novel treatment strategies are required." | 5.17 | Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial. ( Anderson, BJ; Audet, D; Caviness, CM; Kurth, ME; Olson, J; Stein, MD, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stein, MD | 1 |
| Caviness, CM | 1 |
| Kurth, ME | 1 |
| Audet, D | 1 |
| Olson, J | 1 |
| Anderson, BJ | 1 |
| Spiga, R | 1 |
| Schmitz, J | 1 |
| Day, J | 1 |
| Haug, NA | 1 |
| Stitzer, ML | 1 |
| Svikis, DS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Varenicline Versus Nicotine Replacement for Methadone-Maintained Smokers[NCT00790569] | 315 participants (Actual) | Interventional | 2008-09-30 | Completed | |||
| An Innovative Digital Smoking Cessation Intervention for Low-Income Adults With Substance Use Disorder[NCT04419922] | 100 participants (Actual) | Observational | 2020-04-02 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of participants reporting 7-day abstinence at 6-months, confirmed with CO measurement. (NCT00790569)
Timeframe: 6-Months
| Intervention | participants (Number) |
|---|---|
| Arm I | 5 |
| Arm II | 1 |
| Arm III | 11 |
Change in mean cigarettes per day (NCT00790569)
Timeframe: 6-Months
| Intervention | cigarettes/day (Mean) |
|---|---|
| Arm I | -8.7 |
| Arm II | -8.5 |
| Arm III | -7.8 |
Smoking urges was measured on a 0 (not at all) - 100 (strongest feeling possible) scale. Higher values represent greater urge to smoke. Change in smoking urges was calculated as Follow-up score (6 month) - Baseline Score. (NCT00790569)
Timeframe: 6 months
| Intervention | units on a scale (Mean) |
|---|---|
| Arm I | -29.971 |
| Arm II | -25.015 |
| Arm III | -24.177 |
Number of participants reporting 7-day abstinence at 12-months, confirmed with CO measurement. (NCT00790569)
Timeframe: 12 Months
| Intervention | participants (Number) |
|---|---|
| Arm I | 4 |
| Arm II | 1 |
| Arm III | 8 |
Number of participants who self-reported continuous abstinence from their initial quit day (study day 14) to 6 Months (NCT00790569)
Timeframe: 6-Months
| Intervention | participants (Number) |
|---|---|
| Arm I | 2 |
| Arm II | 0 |
| Arm III | 2 |
Reinforcing effects of smoking was measured using the modified version of the Cigarette Evaluation Questionnaire. Participants were asked to indicate on a 12-item scale how smoking made them feel in the prior 30 days on a scale from 1 (Not at all) to 7 (Extremely). Higher values indicated that smoking was a more positive experience for 10 of 12 items. Two items were reverse coded. Change in reinforcing effects of smoking was calculated as Follow-up score (6 month) - Baseline Score. (NCT00790569)
Timeframe: 6 months
| Intervention | units on a scale (Mean) |
|---|---|
| Arm I | -1.005 |
| Arm II | -.683 |
| Arm III | -.761 |
Number of participants with self-reported, 7-day abstinence at 6-months (NCT00790569)
Timeframe: 6 Months
| Intervention | participants (Number) |
|---|---|
| Arm I | 11 |
| Arm II | 3 |
| Arm III | 16 |
Number of participants with self-reported 7-day abstinence at 12-months (NCT00790569)
Timeframe: 12 Months
| Intervention | participants (Number) |
|---|---|
| Arm I | 4 |
| Arm II | 3 |
| Arm III | 11 |
Withdrawal Symptoms were measured using a modified version of the Minnesota Behavior Rating Scale. The scale asked subjects to rate their smoking withdrawal symptoms over the previous 24 hours on a scale from 0 (none) to 4 (severe). Higher values indicate more severe withdrawal symptoms. Change in withdrawal symptoms was calculated as Follow-up score (6 month) - Baseline Score. (NCT00790569)
Timeframe: 6 months
| Intervention | units on a scale (Mean) |
|---|---|
| Arm I | -.222 |
| Arm II | -.163 |
| Arm III | -.113 |
2 trials available for carbon monoxide and Heroin Abuse
| Article | Year |
|---|---|
Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.
Topics: Adult; Benzazepines; Carbon Monoxide; Female; Follow-Up Studies; Guideline Adherence; Heroin Depende | 2013 |
Effects of nicotine on methadone self-administration in humans.
Topics: Adult; Analysis of Variance; Behavior, Addictive; Carbon Monoxide; Drug Interactions; Female; Heroin | 1998 |
1 other study available for carbon monoxide and Heroin Abuse
| Article | Year |
|---|---|
Smoking during pregnancy and intention to quit: a profile of methadone-maintained women.
Topics: Adult; Attitude to Health; Carbon Monoxide; Cotinine; Ethnicity; Female; Follow-Up Studies; Heroin D | 2001 |